{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal Cellgram-LC",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "This phase III clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected hepatic artery."
                        ],
                        "BriefTitle": [
                              "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis"
                        ],
                        "CentralContactEMail": [
                              "jyjeong@pharmicell.com"
                        ],
                        "CentralContactName": [
                              "JIYEOUN JEONG"
                        ],
                        "CentralContactPhone": [
                              "82-2-3496-0134"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "March 2, 2026"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Alcoholic Cirrhosis"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000008107",
                              "D000004066",
                              "D000008108",
                              "D000020751",
                              "D000019973",
                              "D000019966",
                              "D000064419"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Liver Diseases",
                              "Digestive System Diseases",
                              "Liver Diseases, Alcoholic",
                              "Alcohol-Induced Disorders",
                              "Alcohol-Related Disorders",
                              "Substance-Related Disorders",
                              "Chemically-Induced Disorders"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC06",
                              "BC23",
                              "All",
                              "BC25",
                              "BXM"
                        ],
                        "NCTId": [
                              "NCT04689152"
                        ]
                  }
            ]
      }
}